nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB1—peripheral nervous system neoplasm	0.409	1	CbGaD
Clofazimine—ABCB11—Vincristine—peripheral nervous system neoplasm	0.113	0.248	CbGbCtD
Clofazimine—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0707	0.155	CbGbCtD
Clofazimine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0454	0.0997	CbGbCtD
Clofazimine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0454	0.0997	CbGbCtD
Clofazimine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0315	0.0691	CbGbCtD
Clofazimine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0272	0.0597	CbGbCtD
Clofazimine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0253	0.0555	CbGbCtD
Clofazimine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0194	0.0426	CbGbCtD
Clofazimine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0181	0.0397	CbGbCtD
Clofazimine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0178	0.039	CbGbCtD
Clofazimine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0121	0.0266	CbGbCtD
Clofazimine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0116	0.0255	CbGbCtD
Clofazimine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0106	0.0234	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00726	0.0159	CbGbCtD
Clofazimine—Bone pain—Alitretinoin—peripheral nervous system neoplasm	0.000827	0.00609	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Tretinoin—peripheral nervous system neoplasm	0.000805	0.00592	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Isotretinoin—peripheral nervous system neoplasm	0.000805	0.00592	CcSEcCtD
Clofazimine—Bone pain—Vincristine—peripheral nervous system neoplasm	0.000797	0.00587	CcSEcCtD
Clofazimine—Cystitis noninfective—Alitretinoin—peripheral nervous system neoplasm	0.000774	0.0057	CcSEcCtD
Clofazimine—Cystitis—Alitretinoin—peripheral nervous system neoplasm	0.000765	0.00563	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000759	0.00559	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000759	0.00559	CcSEcCtD
Clofazimine—Bladder pain—Alitretinoin—peripheral nervous system neoplasm	0.000717	0.00528	CcSEcCtD
Clofazimine—Embolism venous—Epirubicin—peripheral nervous system neoplasm	0.000687	0.00506	CcSEcCtD
Clofazimine—Skin discolouration—Etoposide—peripheral nervous system neoplasm	0.000685	0.00504	CcSEcCtD
Clofazimine—Lymphadenopathy—Alitretinoin—peripheral nervous system neoplasm	0.000674	0.00496	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—peripheral nervous system neoplasm	0.000636	0.00468	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Alitretinoin—peripheral nervous system neoplasm	0.00061	0.00449	CcSEcCtD
Clofazimine—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.000599	0.00441	CcSEcCtD
Clofazimine—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.000599	0.00441	CcSEcCtD
Clofazimine—Weight decreased—Isotretinoin—peripheral nervous system neoplasm	0.000594	0.00437	CcSEcCtD
Clofazimine—Weight decreased—Tretinoin—peripheral nervous system neoplasm	0.000594	0.00437	CcSEcCtD
Clofazimine—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.000585	0.00431	CcSEcCtD
Clofazimine—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.000585	0.00431	CcSEcCtD
Clofazimine—Depression—Tretinoin—peripheral nervous system neoplasm	0.000583	0.00429	CcSEcCtD
Clofazimine—Depression—Isotretinoin—peripheral nervous system neoplasm	0.000583	0.00429	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.00424	CcSEcCtD
Clofazimine—Jaundice—Melphalan—peripheral nervous system neoplasm	0.000563	0.00414	CcSEcCtD
Clofazimine—Embolism—Epirubicin—peripheral nervous system neoplasm	0.00054	0.00398	CcSEcCtD
Clofazimine—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.000525	0.00387	CcSEcCtD
Clofazimine—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.000525	0.00387	CcSEcCtD
Clofazimine—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.000518	0.00382	CcSEcCtD
Clofazimine—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.000506	0.00373	CcSEcCtD
Clofazimine—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.000506	0.00373	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.00368	CcSEcCtD
Clofazimine—Neuralgia—Epirubicin—peripheral nervous system neoplasm	0.000499	0.00367	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.00049	0.00361	CcSEcCtD
Clofazimine—Hepatomegaly—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00361	CcSEcCtD
Clofazimine—Neuralgia—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.0034	CcSEcCtD
Clofazimine—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00334	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00334	CcSEcCtD
Clofazimine—Weight decreased—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00331	CcSEcCtD
Clofazimine—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.000446	0.00328	CcSEcCtD
Clofazimine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.00326	CcSEcCtD
Clofazimine—Depression—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.00325	CcSEcCtD
Clofazimine—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.000437	0.00322	CcSEcCtD
Clofazimine—Weight decreased—Vincristine—peripheral nervous system neoplasm	0.000434	0.00319	CcSEcCtD
Clofazimine—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.000429	0.00316	CcSEcCtD
Clofazimine—Depression—Vincristine—peripheral nervous system neoplasm	0.000426	0.00314	CcSEcCtD
Clofazimine—Anaemia—Topotecan—peripheral nervous system neoplasm	0.000426	0.00314	CcSEcCtD
Clofazimine—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.000423	0.00311	CcSEcCtD
Clofazimine—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.000423	0.00311	CcSEcCtD
Clofazimine—Anaemia—Melphalan—peripheral nervous system neoplasm	0.000417	0.00307	CcSEcCtD
Clofazimine—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.000398	0.00293	CcSEcCtD
Clofazimine—Skin discolouration—Epirubicin—peripheral nervous system neoplasm	0.000384	0.00283	CcSEcCtD
Clofazimine—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.00282	CcSEcCtD
Clofazimine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.000373	0.00275	CcSEcCtD
Clofazimine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.000373	0.00275	CcSEcCtD
Clofazimine—Oedema—Melphalan—peripheral nervous system neoplasm	0.000368	0.00271	CcSEcCtD
Clofazimine—Bone pain—Epirubicin—peripheral nervous system neoplasm	0.000362	0.00267	CcSEcCtD
Clofazimine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000359	0.00264	CcSEcCtD
Clofazimine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000356	0.00262	CcSEcCtD
Clofazimine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000356	0.00262	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.00262	CcSEcCtD
Clofazimine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000351	0.00258	CcSEcCtD
Clofazimine—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000345	0.00254	CcSEcCtD
Clofazimine—Cystitis noninfective—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00249	CcSEcCtD
Clofazimine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000337	0.00248	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.00247	CcSEcCtD
Clofazimine—Cystitis—Epirubicin—peripheral nervous system neoplasm	0.000335	0.00247	CcSEcCtD
Clofazimine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000332	0.00244	CcSEcCtD
Clofazimine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000332	0.00244	CcSEcCtD
Clofazimine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000327	0.00241	CcSEcCtD
Clofazimine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000327	0.00241	CcSEcCtD
Clofazimine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000324	0.00239	CcSEcCtD
Clofazimine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000324	0.00239	CcSEcCtD
Clofazimine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000324	0.00239	CcSEcCtD
Clofazimine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000322	0.00237	CcSEcCtD
Clofazimine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000322	0.00237	CcSEcCtD
Clofazimine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000322	0.00237	CcSEcCtD
Clofazimine—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00032	0.00236	CcSEcCtD
Clofazimine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00032	0.00236	CcSEcCtD
Clofazimine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000319	0.00235	CcSEcCtD
Clofazimine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000319	0.00235	CcSEcCtD
Clofazimine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000318	0.00234	CcSEcCtD
Clofazimine—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.000314	0.00231	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00231	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00228	CcSEcCtD
Clofazimine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000309	0.00227	CcSEcCtD
Clofazimine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000305	0.00225	CcSEcCtD
Clofazimine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000297	0.00219	CcSEcCtD
Clofazimine—Lymphadenopathy—Epirubicin—peripheral nervous system neoplasm	0.000295	0.00217	CcSEcCtD
Clofazimine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000295	0.00217	CcSEcCtD
Clofazimine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000295	0.00217	CcSEcCtD
Clofazimine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000291	0.00214	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00214	CcSEcCtD
Clofazimine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.00208	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.00201	CcSEcCtD
Clofazimine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000273	0.00201	CcSEcCtD
Clofazimine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000273	0.00201	CcSEcCtD
Clofazimine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00027	0.00199	CcSEcCtD
Clofazimine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00198	CcSEcCtD
Clofazimine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000268	0.00197	CcSEcCtD
Clofazimine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000268	0.00197	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000267	0.00196	CcSEcCtD
Clofazimine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000266	0.00196	CcSEcCtD
Clofazimine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000265	0.00195	CcSEcCtD
Clofazimine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000264	0.00195	CcSEcCtD
Clofazimine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000264	0.00194	CcSEcCtD
Clofazimine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000264	0.00194	CcSEcCtD
Clofazimine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000263	0.00194	CcSEcCtD
Clofazimine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000261	0.00192	CcSEcCtD
Clofazimine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00026	0.00191	CcSEcCtD
Clofazimine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000257	0.00189	CcSEcCtD
Clofazimine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000255	0.00188	CcSEcCtD
Clofazimine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00188	CcSEcCtD
Clofazimine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000252	0.00186	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00185	CcSEcCtD
Clofazimine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00185	CcSEcCtD
Clofazimine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00025	0.00184	CcSEcCtD
Clofazimine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000249	0.00183	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.00182	CcSEcCtD
Clofazimine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000247	0.00182	CcSEcCtD
Clofazimine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000247	0.00182	CcSEcCtD
Clofazimine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00181	CcSEcCtD
Clofazimine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.00179	CcSEcCtD
Clofazimine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00178	CcSEcCtD
Clofazimine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000241	0.00177	CcSEcCtD
Clofazimine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000241	0.00177	CcSEcCtD
Clofazimine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000239	0.00176	CcSEcCtD
Clofazimine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000237	0.00175	CcSEcCtD
Clofazimine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000237	0.00175	CcSEcCtD
Clofazimine—Rash—Topotecan—peripheral nervous system neoplasm	0.000237	0.00175	CcSEcCtD
Clofazimine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000237	0.00174	CcSEcCtD
Clofazimine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000237	0.00174	CcSEcCtD
Clofazimine—Headache—Topotecan—peripheral nervous system neoplasm	0.000236	0.00173	CcSEcCtD
Clofazimine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000235	0.00173	CcSEcCtD
Clofazimine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000235	0.00173	CcSEcCtD
Clofazimine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000235	0.00173	CcSEcCtD
Clofazimine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000235	0.00173	CcSEcCtD
Clofazimine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000235	0.00173	CcSEcCtD
Clofazimine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000234	0.00172	CcSEcCtD
Clofazimine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000234	0.00172	CcSEcCtD
Clofazimine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000234	0.00172	CcSEcCtD
Clofazimine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000233	0.00172	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00171	CcSEcCtD
Clofazimine—Rash—Melphalan—peripheral nervous system neoplasm	0.000232	0.00171	CcSEcCtD
Clofazimine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000232	0.00171	CcSEcCtD
Clofazimine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00023	0.00169	CcSEcCtD
Clofazimine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00023	0.00169	CcSEcCtD
Clofazimine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00169	CcSEcCtD
Clofazimine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.00165	CcSEcCtD
Clofazimine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000223	0.00164	CcSEcCtD
Clofazimine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000222	0.00163	CcSEcCtD
Clofazimine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000222	0.00163	CcSEcCtD
Clofazimine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000219	0.00161	CcSEcCtD
Clofazimine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000219	0.00161	CcSEcCtD
Clofazimine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00159	CcSEcCtD
Clofazimine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000215	0.00159	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00157	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00156	CcSEcCtD
Clofazimine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00021	0.00155	CcSEcCtD
Clofazimine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00154	CcSEcCtD
Clofazimine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000209	0.00154	CcSEcCtD
Clofazimine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00149	CcSEcCtD
Clofazimine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.00147	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00147	CcSEcCtD
Clofazimine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00146	CcSEcCtD
Clofazimine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00145	CcSEcCtD
Clofazimine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00144	CcSEcCtD
Clofazimine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000196	0.00144	CcSEcCtD
Clofazimine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000196	0.00144	CcSEcCtD
Clofazimine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00143	CcSEcCtD
Clofazimine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000194	0.00143	CcSEcCtD
Clofazimine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.00142	CcSEcCtD
Clofazimine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000192	0.00142	CcSEcCtD
Clofazimine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000192	0.00141	CcSEcCtD
Clofazimine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00019	0.0014	CcSEcCtD
Clofazimine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00019	0.0014	CcSEcCtD
Clofazimine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00139	CcSEcCtD
Clofazimine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000189	0.00139	CcSEcCtD
Clofazimine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.00138	CcSEcCtD
Clofazimine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000186	0.00137	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00135	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00134	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00134	CcSEcCtD
Clofazimine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000181	0.00133	CcSEcCtD
Clofazimine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00018	0.00133	CcSEcCtD
Clofazimine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.00132	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00132	CcSEcCtD
Clofazimine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.00131	CcSEcCtD
Clofazimine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.00131	CcSEcCtD
Clofazimine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.0013	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00129	CcSEcCtD
Clofazimine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000175	0.00128	CcSEcCtD
Clofazimine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00128	CcSEcCtD
Clofazimine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000173	0.00128	CcSEcCtD
Clofazimine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000173	0.00127	CcSEcCtD
Clofazimine—Rash—Vincristine—peripheral nervous system neoplasm	0.000172	0.00126	CcSEcCtD
Clofazimine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000172	0.00126	CcSEcCtD
Clofazimine—Headache—Vincristine—peripheral nervous system neoplasm	0.000171	0.00126	CcSEcCtD
Clofazimine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.00124	CcSEcCtD
Clofazimine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00124	CcSEcCtD
Clofazimine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00121	CcSEcCtD
Clofazimine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000162	0.00119	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00119	CcSEcCtD
Clofazimine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000158	0.00117	CcSEcCtD
Clofazimine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000156	0.00115	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00114	CcSEcCtD
Clofazimine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000153	0.00113	CcSEcCtD
Clofazimine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00112	CcSEcCtD
Clofazimine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00112	CcSEcCtD
Clofazimine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000151	0.00111	CcSEcCtD
Clofazimine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000146	0.00107	CcSEcCtD
Clofazimine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000143	0.00105	CcSEcCtD
Clofazimine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00014	0.00103	CcSEcCtD
Clofazimine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00103	CcSEcCtD
Clofazimine—Rash—Etoposide—peripheral nervous system neoplasm	0.000139	0.00102	CcSEcCtD
Clofazimine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000139	0.00102	CcSEcCtD
Clofazimine—Headache—Etoposide—peripheral nervous system neoplasm	0.000138	0.00102	CcSEcCtD
Clofazimine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000131	0.000965	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000955	CcSEcCtD
Clofazimine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000911	CcSEcCtD
Clofazimine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000868	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000843	CcSEcCtD
Clofazimine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00081	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000803	CcSEcCtD
Clofazimine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000792	CcSEcCtD
Clofazimine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000785	CcSEcCtD
Clofazimine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000779	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000749	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000733	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.87e-05	0.000727	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000721	CcSEcCtD
Clofazimine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.78e-05	0.00072	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.05e-05	0.000666	CcSEcCtD
Clofazimine—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000654	CcSEcCtD
Clofazimine—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000644	CcSEcCtD
Clofazimine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000623	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000605	CcSEcCtD
Clofazimine—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000602	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000596	CcSEcCtD
Clofazimine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000579	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000577	CcSEcCtD
Clofazimine—Rash—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000574	CcSEcCtD
Clofazimine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000574	CcSEcCtD
Clofazimine—Headache—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000571	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000557	CcSEcCtD
Clofazimine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000541	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000536	CcSEcCtD
Clofazimine—Rash—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000531	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.21e-05	0.000531	CcSEcCtD
Clofazimine—Headache—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000528	CcSEcCtD
Clofazimine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000501	CcSEcCtD
